More than half of all US adults are eligible for semaglutide therapy

Over 137 million US adults are eligible for semaglutide, driven by expanding indications for diabetes, weight management, and cardiovascular disease prevention.

USC scientists develop first all-human brain organoids model of the cerebellum with functional neurons

In a first for USC Stem Cell scientists, the laboratory of Giorgia Quadrato, an assistant professor of stem cell biology and regenerative medicine, has pioneered

January 5, 2024

Emergent wins $75m BARDA contact for anthrax vaccine

Share this article The current $75m contract option builds on an existing Cyfendus development contract between Emergent and BARDA. Image Credit: Niyazz / Shutterstock. Emergent

November 28, 2023

Apple Watches are back on sale while federal court reviews patent suit

Apple Watches are back on the market. In a last minute win for the company, the U.S. Court of Appeals approved Apple’s request to continue

December 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.